Date Filed | Type | Description |
10/05/2023 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 100,450 options to buy
@ $6.41, valued at
$643.9k
|
|
10/05/2023 |
4
| Race Geoff (President) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 87,050 options to buy
@ $6.41, valued at
$558k
|
|
10/05/2023 |
4
| Ahlholm Frederick W (SVP, CFO and Secretary) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 42,850 options to buy
@ $6.41, valued at
$274.7k
|
|
09/29/2023 |
4
| HASLER HANS PETER (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.3, valued at
$91.3k
|
|
09/29/2023 |
4
| VAN HEEK G JAN (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.3, valued at
$91.3k
|
|
09/29/2023 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.3, valued at
$91.3k
|
|
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/07/2023 |
3
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH (10% Owner) has filed a Form 3 on Minerva Neurosciences, Inc. |
05/02/2023 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 88,077 shares
@ $0 Sold 23,753 shares
@ $3.85, valued at
$91.4k
Sold 3,641 shares
@ $3.76, valued at
$13.7k
|
|
05/02/2023 |
4
| Race Geoff (President) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 46,987 shares
@ $0 Sold 22,082 shares
@ $3.85, valued at
$85k
|
|
05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 2,500 options to buy
@ $0 |
|
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Kupfer David (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 2,500 options to buy
@ $0 |
|
06/28/2022 |
4
| Laghrissi-Thode Fouzia (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 2,500 options to buy
@ $0 |
|
02/18/2022 |
4
| Ahlholm Frederick W (CFO) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 180,000 options to buy
@ $0.791, valued at
$142.4k
|
|
02/18/2022 |
4
| Race Geoff (President) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 200,000 options to buy
@ $0.791, valued at
$158.2k
|
|
02/18/2022 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 505,000 options to buy
@ $0.791, valued at
$399.5k
|
|
12/03/2021 |
4
| Kupfer David (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Sold 55,635 shares
@ $0.88, valued at
$49k
|
|
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2021 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 40,000 options to buy
@ $2.9, valued at
$116k
|
|
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2021 |
4
| Laghrissi-Thode Fouzia (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $2.9, valued at
$58k
|
|
06/15/2021 |
4
| Kupfer David (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $2.9, valued at
$58k
|
|
12/16/2020 |
4
| Reilly Joseph H. (SVP & COO) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Sold 3,228 shares
@ $2.64, valued at
$8.5k
Exercised 8,750 restricted stock units
@ $0 |
|
|